Page last updated: 2024-08-24

oseltamivir and Obesity, Morbid

oseltamivir has been researched along with Obesity, Morbid in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Goralski, KB; Hatchette, TF; Johnston, BL; McNeil, SA; Slayter, KL; Thorne-Humphrey, LM1

Trials

1 trial(s) available for oseltamivir and Obesity, Morbid

ArticleYear
Oseltamivir pharmacokinetics in morbid obesity (OPTIMO trial).
    The Journal of antimicrobial chemotherapy, 2011, Volume: 66, Issue:9

    Topics: Adult; Antiviral Agents; Area Under Curve; Biotransformation; Body Mass Index; Dose-Response Relationship, Drug; Double-Blind Method; Female; Half-Life; Humans; Male; Middle Aged; Obesity, Morbid; Oseltamivir; Prodrugs; Young Adult

2011